Primary endpoint analysis of the multicentre phase II hypo-FLAME trial for intermediate and high risk prostate cancer-Reference-Cited by-同舟云学术

Primary endpoint analysis of the multicentre phase II hypo-FLAME trial for intermediate and high risk prostate cancer

Published:2020-06 Issue: Volume:147 Page:92-98
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Draulans Cédric,van der Heide Uulke A.,Haustermans Karin,Pos Floris J.,van der Voort van Zyp Jochem,De Boer Hans,Groen Veerle H.,Monninkhof Evelyn M.,Smeenk Robert J.,Kunze-Busch Martina,De Roover Robin,Depuydt Tom,Isebaert Sofie,Kerkmeijer Linda G.W.

Funder

Kom op tegen Kanker

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference37 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018

2. Higher-than-conventional radiation doses in localized prostate cancer treatment: a meta-analysis of randomized, controlled trials;Viani;Int J Radiat Oncol Biol Phys,2009

3. Effect of increasing radiation doses on local and distant failures in patients with localized prostate cancer;Kupelian;Int J Radiat Oncol Biol Phys,2008

4. Dose escalation for prostate cancer radiotherapy: predictors of long-term biochemical tumor control and distant metastases? Free survival outcomes;Zelefsky;Eur Urol,2011

5. Radiotherapy doses of 80 Gy and higher are associated with lower mortality in men with Gleason score 8 to 10 prostate cancer;Pahlajani;Int J Radiat Oncol Biol Phys,2012

Cited by 121 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Simultaneous Focal Boost With Stereotactic Radiation Therapy for Localized Intermediate- to High-Risk Prostate Cancer: Primary Outcomes of the SPARC Phase 2 Trial;International Journal of Radiation Oncology*Biology*Physics;2024-09

2. Volumetric Modulated Arc Therapy for High-Risk and Very High-Risk Locoregional Prostate Cancer in the Modern Era: Real-World Experience from an Asian Cohort;Cancers;2024-08-25

3. Target Volume Optimization for Localized Prostate Cancer;Practical Radiation Oncology;2024-07

4. Ablative Radiation Therapy for Unfavorable Prostate Tumors (ABRUPT): Preliminary Analysis of Toxicity and Quality of Life from a Prospective Study;International Journal of Radiation Oncology*Biology*Physics;2024-07

5. The role of a radiopaque peri-rectal hydrogel spacer in aiding accurate daily image-guidance for prostate stereotactic radiotherapy;Frontiers in Oncology;2024-06-18